Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prognostic Factors Based on Clinicopathological Data Among the Patients with Resected Peripheral Squamous Cell Carcinomas of the Lung  Tomonari Kinoshita,

Similar presentations


Presentation on theme: "Prognostic Factors Based on Clinicopathological Data Among the Patients with Resected Peripheral Squamous Cell Carcinomas of the Lung  Tomonari Kinoshita,"— Presentation transcript:

1 Prognostic Factors Based on Clinicopathological Data Among the Patients with Resected Peripheral Squamous Cell Carcinomas of the Lung  Tomonari Kinoshita, MD, Takashi Ohtsuka, MD, PhD, Tai Hato, MD, PhD, Taichiro Goto, MD, PhD, Ikuo Kamiyama, MD, Atsushi Tajima, MD, PhD, Katsura Emoto, MD, Yuichiro Hayashi, MD, Mitsutomo Kohno, MD, PhD  Journal of Thoracic Oncology  Volume 9, Issue 12, Pages (December 2014) DOI: /JTO Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Representative elastica van Gieson staining. Pleural invasion (A) and vascular invasion (B) case of peripheral squamous cell carcinoma of the lung. Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Recurrence-free survival curves for patients with p-SqCCs of all stages according to vascular invasion (A), pleural invasion (B), and serum SCC level (C). Recurrence-free survival curves for patients with p-SqCCs of pathological stage I according to vascular invasion (D), pleural invasion (E), and serum SCC level (F). p-SqCCs, peripheral squamous cell carcinomas; SCC, squamous cell carcinoma antigen. Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 T1 with high serum squamous cell carcinoma antigen level or vascular invasion was upgraded to T2a. Recurrence-free survival curves for patients with peripheral squamous cell carcinoma of preclassified and postclassified all stages according to T factor (T2a versus T1, new T2a versus new T1) (A, B) and pathological stage (IA versus IB, new IA versus new IB) (C, D). Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions


Download ppt "Prognostic Factors Based on Clinicopathological Data Among the Patients with Resected Peripheral Squamous Cell Carcinomas of the Lung  Tomonari Kinoshita,"

Similar presentations


Ads by Google